KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $21.8 billion.

  • Amgen's Total Current Liabilities rose 728.14% to $21.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 billion, marking a year-over-year increase of 728.14%. This contributed to the annual value of $23.1 billion for FY2024, which is 2559.26% up from last year.
  • As of Q3 2025, Amgen's Total Current Liabilities stood at $21.8 billion, which was up 728.14% from $20.5 billion recorded in Q2 2025.
  • Amgen's Total Current Liabilities' 5-year high stood at $23.1 billion during Q4 2024, with a 5-year trough of $12.2 billion in Q4 2021.
  • In the last 5 years, Amgen's Total Current Liabilities had a median value of $17.0 billion in 2023 and averaged $17.2 billion.
  • In the last 5 years, Amgen's Total Current Liabilities skyrocketed by 4912.09% in 2021 and then crashed by 1348.65% in 2022.
  • Quarter analysis of 5 years shows Amgen's Total Current Liabilities stood at $12.2 billion in 2021, then grew by 28.75% to $15.7 billion in 2022, then grew by 17.24% to $18.4 billion in 2023, then increased by 25.59% to $23.1 billion in 2024, then dropped by 5.66% to $21.8 billion in 2025.
  • Its Total Current Liabilities stands at $21.8 billion for Q3 2025, versus $20.5 billion for Q2 2025 and $23.0 billion for Q1 2025.